Background. Unlike creatinine, Cystatin C (CysC) is believed to be independent of body composition in both adults and children. Recent findings in adults, suggesting an improved performance of CysC-based estimated glomerular filtration rate (CysC eGFR) by accounting for body mass, necessitated a careful re-evaluation of this issue in children. Methods. We studied 240 children (median age 11.7 years, range 2-17.9 years, 107 girls), with various kidney diseases, for any change in the relationship between 99 Tc DTPA GFR and CysC eGFR after accounting for body mass. For body mass assessment, body mass index (BMI) z-score was calculated using height-adjusted age, to account for growth retardation secondary to chronic kidney disease. Results. CysC eGFR did not have a significant correlation with BMI z-score (correlation coefficient = 0.06; P = 0.34). Accounting for BMI z-score did not add to the 65% variance in nuclear GFR explained by CysC eGFR. Moreover, it did not change the regression coefficient of 0.85 between CysC eGFR and nuclear GFR either. On Bland & Altman analysis, the bias of 0.05 and standard deviation of 20.39 also did not improve after accounting for BMI z-score in the revised CysC eGFR formula. Conclusions. In children, body mass exerts a minimal effect on the performance of CysC eGFR estimation.
Introduction
Glomerular filtration rate (GFR) determination is essential for the management of patients with kidney disease. For a direct GFR estimation, inulin clearance is the goldstandard method; however, it is expensive, cumbersome and Correspondence and offprint requests to: Guido Filler, Children's Hospital, London Health Science Centre, University of Western Ontario, 800 Commissioner's Road East, London, Ontario, N6A 5W9, Canada. Tel: +1-519-685-8377; Fax: +1-519-685-8551; E-mail: guido.filler@lhsc.on.ca is not readily available at many centres. As a result, nuclear medicine techniques have largely replaced inulin clearance in routine clinical practice. Despite the advantage of a direct GFR assessment, radiation exposure, associated cost and multiple blood samples limit a frequent use of nuclear medicine techniques in an individual patient [1, 2] . Consequently, frequent kidney function assessments largely rely on estimated GFR (eGFR) derived from endogenous surrogate markers.
Conventionally, creatinine has been the most frequently used surrogate marker for eGFR estimation. Recently, Cystatin C (CysC) has been found to have a 10% better diagnostic performance than serum creatinine in mild renal impairment [3] . Regardless of the marker or the formula used to calculate eGFR, a 30-40% scatter between measured GFR and eGFR remains unexplained. Imprecision of the analytical methods can account for only 10% of the variance [4] . Although the recognized effect of muscle mass on serum creatinine-based eGFR can further explain a part of the scatter, a similar confounding effect of body mass on CysC eGFR is not clear. The body mass and CysC relationship has been the focus of a few recent adult and paediatric studies.
Earlier, Vinge et al. demonstrated no correlation between CysC and lean tissue mass in 42 healthy young adults with normal renal functions [5] . Similarly, Bökenkamp et al. did not find any correlation of CysC with weight or height in children with chronic kidney disease (CKD) [6] . In contrast, Galteau et al. reported a moderate correlation between body mass index (BMI) and CysC in older subjects, but no such association existed in the enrolled children [7] . This large study on 1223 subjects raised a possibility of different relationship between body composition and CysC eGFR in adults and children.
To expand on this debate, MacDonald et al. reported 6% variance in CysC by lean mass, and 16% improved performance by accounting for body mass in the CysC eGFR formula, despite no direct correlation between body mass and CysC similar to the earlier studies [8] . This study involved adult CKD patients. We are not aware of any similar paediatric study that assessed the effect of body mass on CysC variance, and evaluated the performance of CysC Evaluating the clinical significance of body mass in GFR estimation 471 eGFR estimation after accounting for body mass. Based on the fact that CysC is generated from all the nucleated cells in the body [9, 10] , we hypothesized a similar effect of body mass on CysC in children too, although the degree of effect may be different in children due to their smaller body sizes.
To test this hypothesis, we assessed CysC variance secondary to body mass in paediatric CKD patients. In addition, we analysed any improvement in the correlation between nuclear GFR and CysC eGFR by accounting for body mass.
Subjects and methods
The study was approved by the Institutional Review Board approval. We performed a post hoc analysis of the prospectively collected data on nuclear GFR and CysC levels from 240 children referred to the paediatric nephrology clinic. These measurements occurred within a larger study of 536 children enrolled to derive the CysC formula [4] . The data on age, weight, and height were collected to calculate body surface area (BSA), BMI and BMI z-scores [11] . Patients with nuclear GFR estimated by 51 CR EDTA, or with incomplete anthropometric measurements, were excluded. Patients aged 2 years or younger were also excluded due to unavailability of reference data for BMI z-score calculation.
Nuclear GFR was measured using a 99 m technetiumdiethylene-triamine penta-acetic acid ( 99 mTc DTPA) renal scan with a three-point sampling approach at 2, 3 and 4 h post-injection according to Russell [12] . As per conventional practice, the measured 99 mTc DTPA GFR was normalized to BSA of 1.73 m 2 , to account for the change in body size with age. BSA and BMI were calculated by the Haycock formula [13] , and by the ratio of weight (kg) and square of height (m), respectively. To calculate BMI z-scores, age and gender-specific standard deviations (SDs) published by the National Center for Health Statistics [14] were used. The method to test CysC (nephelometry, Dade Behring kit) has been described elsewhere [15] . CysC eGFR was determined using the previously published formula, using regression analysis of the log-log transformed data [15] . It reads CysC eGFR = 10ˆ(1.962 + 1.123 log(1/CysC)) (mL/min/1.73 m 2 ) (formula 1). The old formula was updated for this specific data set with the changed constants accordingly. The formula now reads CysC eGFR = 10ˆ(1.948 + 1.184 log(1/CysC)); R = 0.921, R 2 = 0.848 (formula 2).
With the CysC eGFR derived from formula 2, we built the following regression models to analyse the relationship between nuclear GFR and CysC eGFR for the entire group, and also separately in females and males, with and without accounting for BMI z-score. Notably, BMI z-score estimation was done for both chronological age (model 2) and height-adjusted age (model 3). The use of height-adjusted age was intended to correct for a detrimental effect of CKD on height, as earlier validated by Schaefer et al. [16] .
Entire group
• Model 1: GFR = 19.134 + 0.819 × CysC eGFR (formula 2); R = 0.808, R 2 = 0.653.
• Model 2: GFR = 19.229 + 0.807 × CysC GFR (formula 2) + 3.369 × BMI z-score; R = 0.814, R 2 = 0.662. • Model 3: GFR = 18.635 + 0.816 × CysC eGFR (formula 2) + 2.007 × BMI z-score using height-adjusted age; R = 0.810, R 2 = 0.656. To further analyse the effect of BMI z-score on CysC eGFR, we derived a revised formula for CysC eGFR estimation that incorporated BMI z-score. The revised formula reads CysC eGFR = 10ˆ(1.944 + 1.181 log(1/CysC) + 0.009 × BMI z-score using height-adjusted age (HAA)); R = 0.922, R 2 = 0.850 (formula 3). To account for genderspecific differences, separate formulae were derived for the boys and girls. In boys, without accounting for BMI z-score, it reads GFR = 10ˆ(1.956 + 1.221 log(1/CysC)), R = 0.941, 
Statistical analysis
Wherever possible, simple descriptive statistics were used. Contiguous data were tested for normal distribution using the D'Agostini Pearson omnibus test and the Shapiro-Wilks test. Normally distributed data were analysed using parametric methods (mean, SD, t-test, Pearson correlation); otherwise non-parametric methods were employed (median, range, Wilcoxon's matched pairs test and Spearman rank correlation). All statistical analyses were conducted using GraphPad Prism software, version 4.02 (GraphPad Inc., San Diego, CA, USA). For the multiple regression analyses, SPSS version 15 (SPSS Inc., Chicago, IL, USA) was also utilized. CysC: Cystatin C; BMI: body mass index; GFR: glomerular filtration rate. BMI z-score calculated with height-adjusted age.
Obese group BMI z-score >2.00 corresponding to height-adjusted age. Data are expressed as correlation coefficient (P-value).
Results
The study group constituted 240 patients. Patient characteristics are summarized in Table 1 . Based on the BMI estimation according to the chronological age, BMI z-scores in excess of 2.0 (obese group) were present in 17 (7%) children, whereas corresponding to the height-adjusted age this proportion was 19 (8%).
The correlation between nuclear GFR with CysC eGFR, and also with other variables, is summarized in Table 2 . As expected, nuclear GFR significantly correlated with CysC eGFR [correlation coefficient (c) = 0.83; P < 0.000] (Figure 1 ). On the other hand, nuclear GFR did not have a significant correlation with age, weight, height, BMI and BMI z-score in the whole group or in the separate analyses conducted on both genders and obese children.
On regression analysis, the regression coefficient between nuclear GFR and CysC eGFR, without accounting for BMI z-score, was 0.80 in the whole group (Table 3) , improved to 0.88 in a separate analysis on the boys, and only reached 0.72 in the girls. After accounting for BMI zscore, the regression coefficient improved only marginally to 0.85 in the whole group, dropped minimally to 0.87 in the boys and remained at 0.72 in the girls. In the obese group, the regression coefficient marginally changed from 0.91 to 0.92 after accounting for BMI z-score. Furthermore, Fig. 1 . The correlation coefficient between nuclear GFR (ml/min/ 1.73 m 2 ) and the estimated Cystatin C GFR (ml/min/1.73 m 2 ) after accounting for BMI z-score in the formula for Cystatin C GFR. without accounting for BMI z-score, CysC eGFR explained 65% variance in nuclear GFR in the whole group, 77% in the boys and 51% in the girls. After accounting for BMI z-score, the variance explained by CysC eGFR largely remained unchanged at 65% in the whole group, 78% in boys and 52% in the girls (Table 3 ). In the obese group, CysC eGFR explained 83% variance in nuclear GFR, and it remained unchanged after accounting for BMI z-score.
To evaluate the performance of the CysC eGFR formula that accounted for body mass (formula 3), we compared its agreement with nuclear GFR as compared with the formula that did not account for body mass (formula 2). On Bland & Altman analysis, without accounting for BMI z-score, the respective bias and SD amounted to +0.05 and 20.39 in the whole group (Figure 2) , −0.077 and 17.96 in the boys and +0.05 and 22.77 in the girls (Table 4) . After accounting for BMI z-score in the revised formula, the bias and SD in the whole group turned out to be −0.05 and 20.23, respectively (Figure 3) , with the corresponding values of −0.03 and 22.74 in the boys and −0.03 and 22.74 in the girls. In the obese group also, there was no change in the bias and SD from the respective values of −2.00 and 15.91 after accounting for BMI z-score. 
Discussion
A lack of statistically significant correlation between CysC and body mass in the previous studies on both adults and children led to the earlier belief that CysC-based eGFR is independent of body composition [5] [6] [7] . The validity of this relationship was questioned by a recent study in the adult CKD patients reporting a variance in CysC levels secondary to body mass, and an improved performance of the CysC eGFR formula after accounting for body mass [8] . Based on this new observation, we revisited the relationship between body mass and CysC eGFR in children.
As a first step, we evaluated the correlation between CysC eGFR and BMI z-score. Importantly, to account for age dependence of BMI in children, we calculated the corresponding BMI z-scores. The association between BMI z-score and CysC eGFR did not turn out to be significant either in the whole study sample or in the separate analyses on the boys, girls and obese children. This observation was similar to the lack of correlation between body mass and CysC eGFR in the previous studies in both adults and children [5] [6] [7] .
As the next step, we analysed CysC variance secondary to body mass, and change in the performance of the CysC eGFR formula by accounting for body mass. Without accounting for BMI z-score, the CysC eGFR formula explained 65% variance in nuclear GFR in the whole group, 77% in the boys, 51% in the girls and 83% in the obese group. Accounting for BMI z-score did not change the variance either in the whole group or in the separate subgroup
